2022 Q3 Form 10-Q Financial Statement

#000165495422011233 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $1.758M $636.6K $87.20K
YoY Change 384.17% 213.62%
Cost Of Revenue $1.176M $319.0K $41.08K
YoY Change 1034.75% 358.89% 3188.87%
Gross Profit $581.7K $317.7K $46.12K
YoY Change 124.25% 137.98% 5189.22%
Gross Profit Margin 33.1% 49.9% 52.89%
Selling, General & Admin $6.569M $627.1K $551.7K
YoY Change 725.32% -27.08% 5.5%
% of Gross Profit 1129.23% 197.41% 1196.24%
Research & Development $1.835M $1.635M $1.577M
YoY Change 183.67%
% of Gross Profit 315.4% 514.65% 3420.18%
Depreciation & Amortization $1.229M $1.210M $1.169M
YoY Change 135.03%
% of Gross Profit 211.3% 380.93% 2534.08%
Operating Expenses $8.404M $2.262M $2.129M
YoY Change 482.5% -363.01% 307.12%
Operating Profit -$7.822M -$1.944M -$2.083M
YoY Change 561.03% 167.61% 298.97%
Interest Expense $515.00 $3.417K $15.88K
YoY Change -97.81% 0.0% -258.83%
% of Operating Profit
Other Income/Expense, Net $10.34K $9.060K $146.00
YoY Change -99.28% -101.05%
Pretax Income -$7.822M -$1.954M -$2.100M
YoY Change 574.23% 160.62% 296.21%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$7.822M -$1.954M -$2.100M
YoY Change 574.23% 160.62% 293.23%
Net Earnings / Revenue -444.98% -306.94% -2408.14%
Basic Earnings Per Share
Diluted Earnings Per Share -$511.2K -$203.0K -$218.2K
COMMON SHARES
Basic Shares Outstanding 19.48M shares 144.4M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.417M $1.754M $1.871M
YoY Change 241.92% 189.11% 18613.5%
Cash & Equivalents $2.417M $1.754M $1.871M
Short-Term Investments
Other Short-Term Assets $152.4K $1.275M $813.9K
YoY Change 14.53% 935.43% 2613.03%
Inventory $698.3K $670.5K $337.8K
Prepaid Expenses
Receivables $400.2K
Other Receivables $0.00
Total Short-Term Assets $3.668M $3.699M $3.023M
YoY Change 314.56% 325.42% 7457.65%
LONG-TERM ASSETS
Property, Plant & Equipment $1.351M $1.503M $1.420M
YoY Change 3281.12% 6456.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $116.4K $124.7K $79.60K
YoY Change 6386.07%
Total Long-Term Assets $35.41M $36.71M $37.71M
YoY Change 85.33% 85.87% 20851.78%
TOTAL ASSETS
Total Short-Term Assets $3.668M $3.699M $3.023M
Total Long-Term Assets $35.41M $36.71M $37.71M
Total Assets $39.08M $40.41M $40.74M
YoY Change 95.47% 95.97% 18416.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $109.1K
YoY Change
Accrued Expenses $1.383M $2.598M $1.340M
YoY Change 4223.3% 12532.33% 282.74%
Deferred Revenue
YoY Change
Short-Term Debt $884.0K $1.013M $1.013M
YoY Change -59.55% -40.79% 322.25%
Long-Term Debt Due $376.5K $3.377M $3.377M
YoY Change -81.17% 120.69% 267.01%
Total Short-Term Liabilities $2.643M $6.988M $5.730M
YoY Change -6.33% 194.1% 281.97%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $27.40M $26.90M
YoY Change
Other Long-Term Liabilities $12.51K $18.32K $24.15K
YoY Change -64.55% -54.85%
Total Long-Term Liabilities $12.51K $27.42M $26.92M
YoY Change -64.55% 67466.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.643M $6.988M $5.730M
Total Long-Term Liabilities $12.51K $27.42M $26.92M
Total Liabilities $2.656M $34.41M $32.65M
YoY Change -7.05% 1323.64% 2076.91%
SHAREHOLDERS EQUITY
Retained Earnings -$21.98M -$14.16M -$12.21M
YoY Change 153.74% 88.74%
Common Stock $194.8K $1.444M
YoY Change -86.33% 1.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $36.43M $6.006M -$8.083M
YoY Change
Total Liabilities & Shareholders Equity $39.08M $40.41M $40.74M
YoY Change 95.47% 95.97% 18416.48%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$7.822M -$1.954M -$2.100M
YoY Change 574.23% 160.62% 293.23%
Depreciation, Depletion And Amortization $1.229M $1.210M $1.169M
YoY Change 135.03%
Cash From Operating Activities -$786.6K -$229.3K -$1.390M
YoY Change 49.48% 434.03% 556.42%
INVESTING ACTIVITIES
Capital Expenditures -$245.2K -$424.6K $135.9K
YoY Change -1152.04% 1721.36%
Acquisitions
YoY Change
Other Investing Activities $4.710K $135.9K -$135.9K
YoY Change -110.86% 339650.0%
Cash From Investing Activities -$240.5K -$288.7K -$135.9K
YoY Change 1099.0% 1139.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.646M 545.0K $1.645M
YoY Change 157.38% -16.23% 727.12%
NET CHANGE
Cash From Operating Activities -786.6K -229.3K -$1.390M
Cash From Investing Activities -240.5K -288.7K -$135.9K
Cash From Financing Activities 1.646M 545.0K $1.645M
Net Change In Cash 618.9K 27.08K $119.1K
YoY Change 563.71% -95.37% -1025.52%
FREE CASH FLOW
Cash From Operating Activities -$786.6K -$229.3K -$1.390M
Capital Expenditures -$245.2K -$424.6K $135.9K
Free Cash Flow -$541.4K $195.3K -$1.526M
YoY Change -1.49% -1095.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001014763
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-726546 usd
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
144379308 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
144379308 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
144379308 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
144379308 shares
CY2021Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
3505931 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-20791
dei Entity Registrant Name
EntityRegistrantName
AINOS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
TX
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
75-1974352
dei Entity Address Address Line1
EntityAddressAddressLine1
8880 Rio San Diego Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Ste. 800
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92108
dei City Area Code
CityAreaCode
858
dei Local Phone Number
LocalPhoneNumber
869-2986
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
AIMD
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19478270 shares
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1751499 usd
CY2022Q2 us-gaap Inventory Gross
InventoryGross
670507 usd
CY2022Q2 us-gaap Notes Payable Current
NotesPayableCurrent
1013405 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
213405 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2598468 usd
CY2022Q2 aimd Convertible Notes Payable Noncurrent
ConvertibleNotesPayableNoncurrent
27400000 usd
CY2021Q4 aimd Convertible Notes Payable Noncurrent
ConvertibleNotesPayableNoncurrent
0 usd
CY2022Q2 aimd Operating Lease Liability Non Current
OperatingLeaseLiabilityNonCurrent
18323 usd
CY2021Q4 aimd Operating Lease Liability Non Current
OperatingLeaseLiabilityNonCurrent
30255 usd
CY2021Q4 us-gaap Liabilities
Liabilities
30625054 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
1443793 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1443793 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18943316 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18856430 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14162843 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10108916 usd
CY2022Q2 aimd Translation Adjustment Liability
TranslationAdjustmentLiability
-217946 usd
CY2021Q4 aimd Translation Adjustment Liability
TranslationAdjustmentLiability
5800 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
6006320 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10197107 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
40413042 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
40822161 usd
CY2022Q2 us-gaap Revenues
Revenues
636627 usd
CY2021Q2 us-gaap Revenues
Revenues
202992 usd
us-gaap Revenues
Revenues
723828 usd
us-gaap Revenues
Revenues
205113 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
318963 usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
69508 usd
us-gaap Cost Of Revenue
CostOfRevenue
360042 usd
us-gaap Cost Of Revenue
CostOfRevenue
70757 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
317664 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
133484 usd
us-gaap Gross Profit
GrossProfit
363786 usd
us-gaap Gross Profit
GrossProfit
134356 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1634856 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3212310 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
627104 usd
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
860030 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1178834 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1383011 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
2261960 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
-860030 usd
us-gaap Operating Expenses
OperatingExpenses
4391144 usd
us-gaap Operating Expenses
OperatingExpenses
-1383011 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1944296 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4027358 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1248655 usd
CY2021Q2 aimd Loss On Sale Of Fixed Assets
LossOnSaleOfFixedAssets
-2247 usd
aimd Loss On Sale Of Fixed Assets
LossOnSaleOfFixedAssets
-2247 usd
CY2022Q2 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-18796 usd
CY2021Q2 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-20981 usd
us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-35483 usd
us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-32879 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9060 usd
CY2022Q2 aimd Loss On Sale Of Fixed Assets
LossOnSaleOfFixedAssets
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8914 usd
aimd Loss On Sale Of Fixed Assets
LossOnSaleOfFixedAssets
0 usd
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-9736 usd
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-23228 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-26569 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-35126 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1954032 usd
CY2022Q2 aimd Average Basic And Diluted Net Loss Per Share Attributable To Common Shareholders
AverageBasicAndDilutedNetLossPerShareAttributableToCommonShareholders
-0.01
CY2021Q2 aimd Average Basic And Diluted Net Loss Per Share Attributable To Common Shareholders
AverageBasicAndDilutedNetLossPerShareAttributableToCommonShareholders
-0.01
aimd Average Basic And Diluted Net Loss Per Share Attributable To Common Shareholders
AverageBasicAndDilutedNetLossPerShareAttributableToCommonShareholders
-0.03
aimd Average Basic And Diluted Net Loss Per Share Attributable To Common Shareholders
AverageBasicAndDilutedNetLossPerShareAttributableToCommonShareholders
-0.02
CY2022Q2 aimd Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
144379308 shares
CY2021Q2 aimd Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
124644759 shares
aimd Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
144379308 shares
aimd Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
83583583 shares
CY2022Q2 aimd Net Loss
NetLoss
-1954032 usd
CY2021Q2 aimd Net Loss
NetLoss
-749774 usd
aimd Net Loss
NetLoss
-4053927 usd
aimd Net Loss
NetLoss
-1283781 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
165687 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2119719 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-8082596 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
3417 usd
CY2022Q2 aimd Option Expense Duringperiodsharesstockoptionsexercised
OptionExpenseDuringperiodsharesstockoptionsexercised
40026 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1954032 usd
CY2022Q2 aimd Translation Adjustment
TranslationAdjustment
-165687 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
6006320 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1278179 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
139405 usd
CY2021Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
20000000 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
3417 usd
CY2021Q2 aimd Option Expense Duringperiodsharesstockoptionsexercised
OptionExpenseDuringperiodsharesstockoptionsexercised
90688 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-749774 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
18205557 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10197107 usd
us-gaap Interest Expense
InterestExpense
6834 usd
aimd Option Expenseduringperiodsharesstockoptionsexercised
OptionExpenseduringperiodsharesstockoptionsexercised
80052 usd
us-gaap Net Income Loss
NetIncomeLoss
-4053927 usd
aimd Translation Adjustment
TranslationAdjustment
-223746 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
139405 usd
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
20000000 usd
us-gaap Interest Expense
InterestExpense
6835 usd
aimd Option Expenseduringperiodsharesstockoptionsexercised
OptionExpenseduringperiodsharesstockoptionsexercised
181376 usd
us-gaap Net Income Loss
NetIncomeLoss
-1283781 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
18205557 usd
us-gaap Profit Loss
ProfitLoss
-4053927 usd
us-gaap Profit Loss
ProfitLoss
-1283781 usd
us-gaap Cost Depreciation Amortization And Depletion
CostDepreciationAmortizationAndDepletion
2378835 usd
us-gaap Cost Depreciation Amortization And Depletion
CostDepreciationAmortizationAndDepletion
514850 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
86886 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
188210 usd
aimd Stock Issued For Compensationnoncash
StockIssuedForCompensationnoncash
139405 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
36202 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
32934 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
2247 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-29881 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-139747 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-670507 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3024 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-775909 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-71941 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
802282 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
238110 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
606866 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
333763 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1619153 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-42926 usd
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
424557 usd
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
23312 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
36 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-424557 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23276 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
1400000 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
652395 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
800000 usd
aimd Stock Issued For Compensationnoncash
StockIssuedForCompensationnoncash
0 usd
aimd Payments Of Lease Liabilities
PaymentsOfLeaseLiabilities
-10125 usd
aimd Payments Of Lease Liabilities
PaymentsOfLeaseLiabilities
-1800 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2189875 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
650595 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
146165 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
584393 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-143787 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1751499 usd
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22245 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1753877 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
606638 usd
aimd Issuance Of Convertible Notes For Payables Related Party
IssuanceOfConvertibleNotesForPayablesRelatedParty
26000000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20000000 usd
aimd Stock Issued For Compensationnoncash
StockIssuedForCompensationnoncash
139405 usd
aimd Net Change In Equipment Payable
NetChangeInEquipmentPayable
117185 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
aimd Rou Leased Assets
RouLeasedAssets
62846 usd
CY2022Q1 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0185 pure
CY2022Q1 aimd Maturity Date
MaturityDate
2023-02-28
aimd Total Interest Expense Of Convertible Notes
TotalInterestExpenseOfConvertibleNotes
34486 usd
aimd Total Interest Expense Of Convertible Notes
TotalInterestExpenseOfConvertibleNotes
32775 usd
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021 aimd Non Convertible Notes Payable Related Party
NonConvertibleNotesPayableRelatedParty
129405 usd
aimd Total Non Convertible Notes Payable Addition
TotalNonConvertibleNotesPayableAddition
800000 usd
aimd Debt Instrument Payment
DebtInstrumentPayment
0 usd
aimd Non Convertible Notes Payable Related Party
NonConvertibleNotesPayableRelatedParty
929405 usd
CY2022Q2 aimd Non Convertible Notes Payable Related Party Accrued Interest
NonConvertibleNotesPayableRelatedPartyAccruedInterest
5221 usd
CY2021 aimd Total Non Convertible Notes Payable
TotalNonConvertibleNotesPayable
213405 usd
aimd Non Convertible Notes Payable Related Party Addition
NonConvertibleNotesPayableRelatedPartyAddition
800000 usd
aimd Total Non Convertible Notes Payable
TotalNonConvertibleNotesPayable
1013405 usd
CY2022Q2 aimd Total Non Convertible Notes Payable Accrued Interest
TotalNonConvertibleNotesPayableAccruedInterest
9143 usd
CY2021 aimd Total Convertible And Nonconvertible
TotalConvertibleAndNonconvertible
3589931 usd
aimd Total Convertible And Nonconvertibleaddition
TotalConvertibleAndNonconvertibleaddition
800000 usd
aimd Total Convertible And Nonconvertiblepayment
TotalConvertibleAndNonconvertiblepayment
0 usd
aimd Total Convertible And Nonconvertible
TotalConvertibleAndNonconvertible
4389931 usd
CY2022Q2 aimd Total Convertible And Nonconvertiblepaymentaccrued
TotalConvertibleAndNonconvertiblepaymentaccrued
63159 usd
CY2022Q2 aimd Convertible Notes Amount
ConvertibleNotesAmount
3000000 usd
CY2022Q1 aimd Principal Amount Property
PrincipalAmountProperty
800000 usd
CY2022Q2 aimd Cumulative Accrued Interest
CumulativeAccruedInterest
63159 usd
CY2021Q4 aimd Cumulative Accrued Interest
CumulativeAccruedInterest
28673 usd
aimd Non Current Convertible Notes Payable
NonCurrentConvertibleNotesPayable
27400000 usd
aimd Non Current Convertible Notes Payable
NonCurrentConvertibleNotesPayable
0 usd
CY2022Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
26000000 usd
CY2022Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
1400000 usd
CY2022Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.01
CY2022Q2 aimd Public Offering Percentage
PublicOfferingPercentage
-0.80 pure
CY2022Q1 aimd Total Assets Purchase Price
TotalAssetsPurchasePrice
26000000 usd
CY2022Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
24886023 usd
CY2022Q1 us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
1113977 usd
CY2022Q2 aimd Non Convertible Notes Payable To Related Parties
NonConvertibleNotesPayableToRelatedParties
30855931 usd
CY2021Q4 aimd Non Convertible Notes Payable To Related Parties
NonConvertibleNotesPayableToRelatedParties
3505931 usd
us-gaap Development Costs
DevelopmentCosts
374170 usd
us-gaap Development Costs
DevelopmentCosts
0 usd
CY2022Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
179547 usd
CY2021Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
65156 usd
CY2021Q4 us-gaap Inventory Gross
InventoryGross
0 usd
CY2022Q2 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
35086424 usd
CY2021Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
37329191 usd
CY2022Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3376526 usd
CY2022Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
0 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
26000000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
30594799 usd
CY2022Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
27418323 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
30255 usd
CY2022Q2 us-gaap Liabilities
Liabilities
34406722 usd

Files In Submission

Name View Source Status
0001654954-22-011233-index-headers.html Edgar Link pending
0001654954-22-011233-index.html Edgar Link pending
0001654954-22-011233.txt Edgar Link pending
0001654954-22-011233-xbrl.zip Edgar Link pending
aimd-20220630.xsd Edgar Link pending
aimd_10q.htm Edgar Link pending
aimd_ex101.htm Edgar Link pending
aimd_ex102.htm Edgar Link pending
aimd_ex311.htm Edgar Link pending
aimd_ex312.htm Edgar Link pending
aimd_ex321.htm Edgar Link pending
aimd_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
aimd-20220630_lab.xml Edgar Link unprocessable
aimd-20220630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
aimd-20220630_def.xml Edgar Link unprocessable
aimd_10q_htm.xml Edgar Link completed
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
aimd-20220630_cal.xml Edgar Link unprocessable